Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

USB Piper Jaffray Downgrades Biomet


USB Piper Jaffray downgraded shares of Biomet (BMET) to buy from strong buy because of price.

Analyst Scott Davidson says he continues to strongly believe in the strength of BMET's fundamentals and health of the orthopedic industry. Nevertheless, he thinks a buy rating better reflects both the stock's outstanding run over the past few years (up 150% since March 2000) and the ratio of risk to reward which that run has engendered.

Consistent with his positive long-term view of BMET and the industry, he looks aggressively for an opportunity to return the shares to a strong buy rating, he says. He sees EPS of $1.37 in FY 2002 (May) and has a $53 12-month price target on the stock.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus